ERICA CORRADINO: Open Payments
NPI 1699390872 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 18 payments from 11 companies in 2025. Trend: 2023 $147 · 2024 $280 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| ABBVIE INC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Almatica Pharma LLC | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
Products named: FANAPT, CAPLYTA, REXULTI, VRAYLAR, COBENFY, Auvelity, LOREEV XR, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
